Pretreatment of hepatocyte growth factor gene transfer mediated by octaarginine peptide-modified nanoparticles ameliorates LPS/D-galactosamine- induced hepatitis

Nucleic Acid Therapeutics

Volumn 22, Issue 5, 2012, Pages 360-363

  Hayashi, Yasuhiro ^a   Mizuno, Ryoichi ^a   Ikramy, Khalil A ^b   Akita, Hidetaka ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Assiut University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GALACTOSAMINE; GALACTOSE; JETPOLYETHYLENIMINEGALACTOSE; LIPOPOLYSACCHARIDE; NANOPARTICLE; OCTAARGININE GLYCYLALANYLLEUCYLALANINE; PEPTIDE; PLASMID DNA; POLYETHYLENEIMINE; SCATTER FACTOR; UNCLASSIFIED DRUG;

ACUTE DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; FULMINANT HEPATIC FAILURE; GENE EXPRESSION; GENE TRANSFER; HEPATITIS; INTERMETHOD COMPARISON; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; MULTIFUNCTIONAL ENVELOPETYPE NANODEVICE; NANODEVICE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PHYSICAL CHEMISTRY; POLYDISPERSITY INDEX; PRIORITY JOURNAL; SURVIVAL RATE; ZETA POTENTIAL;

ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; ANIMALS; ASPARTATE AMINOTRANSFERASES; DRUG-INDUCED LIVER INJURY; GALACTOSAMINE; GENE EXPRESSION; GENES, REPORTER; GENETIC THERAPY; HEPATITIS; HEPATOCYTE GROWTH FACTOR; LIPOPOLYSACCHARIDES; LUCIFERASES, FIREFLY; MALE; MICE; MICE, INBRED BALB C; NANOPARTICLES; OLIGOPEPTIDES; PEPTIDES; PLASMIDS; TRANSFECTION;

MUS;

EID: 84870339402     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2012.0352     Document Type: Article

References (14)

1. AKITA, H., MASUDA, T., NISHINO, T., NIIKURA, K., IJIRO, K., and HARASHIMA, H. (2011). Improving in vivo hepatic transfection activity by controlling intracellular trafficking: the function of GALA and maltoriose. Mol. Pharm. 8, 1436-1442.
2. DITTO, A. J., SHAH, P. N., and YUN, Y. H. (2009). Non-viral gene delivery using nanoparticles. Expert Opin. Drug Deliv. 6, 1149-1160.
3. FUJIWARA, K., NAGOSHI, S., OHNO, A., HIRATA, K., OHTA, Y., MOCHIDA, S., TOMIYA, T., HIGASHIO, K., and KUROKAWA, K. (1993). Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology. 18, 1443-1449. (Pubitemid 23348435)
4. HOOFNAGLE, J. H., CARITHERS, R. L, Jr., SHAPIRO, C., and ASCHER, H. (1995). Fulminant hepatic failure: summary of a workshop. Hepatology 21, 240-252.
5. ISHIKI, Y., OHNISHI, H., MUTO, Y., MATSUMOTO, K., and NAKAMURA, T. (1992). Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16, 1227-1235.
6. KHALIL, IA., HAYASHI, Y., MIZUNO, R., and HARASHIMA, H. (2011). Octaarginine-and pH sensitive fusogenic peptidemodified nanoparticles for liver gene delivery. J. Control. Release 156, 374-380.
7. KOGURE, K., MORIGUCHI, R., SASAKI, K., UENO, M., FUTAKI, S., and HARASHIMA, H. (2004). Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. J. Control. Release 98, 317-323. (Pubitemid 38950740)
8. KOSAI, K., MATSUMOTO, K., FUNAKOSHI, H., and NAKAMURA, T. (1999). Hepatocyte growth factor prevents endotoxininduced lethal hepatic failure in mice. Hepatology 30, 151-159. (Pubitemid 29300581)
9. LIU, K. X., KATO, Y., NARUKAWA, M., KIM, D. C., HANANO, M., HIGUCHI, O., NAKAMURA, T., and SUGIYAMA, Y. (1992). Importance of the liver in plasma clearance of hepatocyte growth factors in rats. Am. J. Physiol. 263, G642-G649.
10. MATSUDA, Y., MATSUMOTO, K., YAMADA, A., ICHIDA, T., ASAKURA, H., KOMORIYA, Y., NISHIYAMA, E., and NAKAMURA, T. (1997). Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 26, 81-89. (Pubitemid 27280310)
11. NOMI, T., SHIOTA, G., ISONO, M., SATO, K., and KAWASAKI, H. (2000). Adenovirus-mediated hepatocyte growth factor gene transfer prevents lethal liver failure in rats. Biochem. Biophys. Res. Commun. 278, 338-343.
12. ROOS, F., TERRELL, T. G., GODOWSKI, P. J., CHAMOW, S. M., and SCHWALL, R. H. (1992). Reduction of alpha-naphthylisothiocyanate-induced hepatotoxicity by recombinant human hepatocyte growth factor. Endocrinology 131, 2540-2544.
13. SAKURAI, Y., HATAKEYAMA, H., SATO, Y., AKITA, H., TAKAYAMA, K., KOBAYASHI, S., FUTAKI, S., and HARASHIMA, H. (2011). Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA. Biomaterials 32, 5733-5742.
14. TAKEHARA, T., MATSUMOTO, K., and NAKAMURA, T. (1992). Cell density-dependent regulation of albumin synthesis and DNA synthesis in rat hepatocytes by hepatocyte growth factor. J. Biochem. 112, 330-334.